🇺🇸 Femoston in United States

245 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 44 reports (17.96%)
  2. Headache — 39 reports (15.92%)
  3. Diarrhoea — 22 reports (8.98%)
  4. Malaise — 22 reports (8.98%)
  5. Vomiting — 22 reports (8.98%)
  6. Myalgia — 21 reports (8.57%)
  7. Nausea — 20 reports (8.16%)
  8. Dyspnoea — 19 reports (7.76%)
  9. Disturbance In Attention — 18 reports (7.35%)
  10. Weight Increased — 18 reports (7.35%)

Source database →

Femoston in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Femoston approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Femoston in United States?

Affiliated Hospital of Nantong University is the originator. The local marketing authorisation holder may differ — check the official source linked above.